Related Experiment Video

Updated: Aug 23, 2026

Protein Misfolding Cyclic Amplification of Prions
10:12

Protein Misfolding Cyclic Amplification of Prions

Published on: November 7, 2012

Destabilization of the non-pathogenic, cellular prion-protein by a small molecular drug

Hans-Joachim Ochel1, Günther Gademann

  • 1Clinic for Radiation Therapy, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany. hans-joachim.ochel@medizin.uni-magdeburg.de

Antiviral Therapy
|July 21, 2004
PubMed

Insights

Novobiocin and coumermycin A1 deplete cellular prion-protein (PrPc), a prerequisite for transmissible spongiform encephalopathies (TSEs). This targeted approach offers new avenues for studying and potentially treating these fatal neurodegenerative diseases.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Cell Biology

Background:

  • Transmissible spongiform encephalopathies (TSEs) are fatal neurodegenerative diseases.
  • The normal cellular prion-protein (PrPc) is essential for TSE development.
  • Targeting PrPc offers a potential therapeutic strategy for TSEs.

Purpose of the Study:

  • To investigate the effect of novobiocin on cellular prion-protein (PrPc) levels.
  • To explore the potential of coumarin antibiotics in modulating PrPc.
  • To identify pharmacological strategies for targeting PrPc stability.

Main Methods:

  • Treatment of eukaryotic cells with novobiocin and coumermycin A1.
  • Dose- and time-dependency studies of novobiocin's effects.
  • Investigating the role of heat-shock protein 90 (Hsp90) and protease inhibitors.

Main Results:

  • Novobiocin and coumermycin A1 rapidly deplete PrPc in a dose- and time-dependent manner.
  • Cellular proliferation was unaffected post-treatment, indicating no permanent damage.
  • Hsp90 inhibition partially antagonized PrPc depletion, while protease inhibitors prevented it.

Conclusions:

  • The stability of normal cellular prion-protein (PrPc) can be pharmacologically targeted.
  • Novobiocin and related coumarins offer a novel approach to PrPc modulation.
  • These findings open new avenues for TSE research and potential therapeutic interventions.

More Related Videos

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes10:33

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

Real-time Quaking-induced Conversion Assay for Detection of CWD Prions in Fecal Material09:50

Real-time Quaking-induced Conversion Assay for Detection of CWD Prions in Fecal Material

Published on: September 29, 2017

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Molecular Chaperones and Protein Folding03:00

Molecular Chaperones and Protein Folding

The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...